Ralf Weiskirchen
University Hospital Aachen, Germany
Editorial board member profile and journal affiliation.
University Hospital Aachen, Germany
<p>
<strong>Biography:</strong>Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry,RWTH University Hospital Aachen, Pauwelsstr. 30<br />
D-52074 Aachen, Germany</p>
<p>
<strong>Education and degrees:</strong></p>
<p>
(1970-1974) Primary school, Catholic elementary school in Bergisch Gladbach (NRW)</p>
<p>
(1974-1983) Secondary school, Dietrich-Bonhoeffer-Gymnasium in Bergisch Gladbach</p>
<p>
(1983-1989) University of Cologne, Studies in Biology</p>
<p>
(1988-1989) Diploma thesis at the Institute of Biochemistry, Faculty of Science, University of Cologne</p>
<p>
(1989-1990) Alternative service at the Institute of Clinical Chemistry, Medical Faculty, University Hospital of Cologne</p>
<p>
(1990-1994) Doctoral thesis (PhD) at the Institute of Biochemistry, Medical Faculty, University of Cologne</p>
<p>
(1994) PhD thesis (summa cum laude)</p>
<p>
(2001) Habilitation and Venia legendi in Pathobiochemistry and Molecular Biology</p>
<p>
(2007) Professor assignment</p>
<p>
</p>
<p>
<strong>Research Interest(s):</strong></p>
<ul>
<li>
Functional analysis of PDGF and TGF-beta signaling in hepatic fibrogenesis</li>
<li>
Development of novel therapeutic strategies for the treatment of liver fibrosis</li>
<li>
Characterization of novel animal models for the study of organ fibrosis</li>
<li>
Transcriptional targeting of hepatic stellate cells</li>
<li>
Functional and structural analysis of LIM domain proteins (eg CRP2)</li>
<li>
Development of novel, gene-based tests for analysis fibrosis progression and predisposition</li>
<li>
Adenoviral expression technology</li>
</ul>